Pharmacology teaches us how drugs work in the human body, but in clinical midwifery practice, two patients rarely react identically to the exact same dose of a medication like oxytocin or magnesium sulfate. Pharmacokinetics refers to what the body does to the drug—encompassing absorption, distribution, metabolism, and excretion. Pharmacodynamics describes what the drug does to the body, including receptor binding and cellular response. Variability occurs because physiological processes differ widely across human populations. A drug that achieves a therapeutic plasma level in a healthy postpartum woman might cause toxicity in a woman with impaired renal function. Understanding these underlying differences prevents medication errors and ensures safer obstetric care in Nigerian clinical settings.
Age significantly alters how drugs behave in the body.
Body size directly influences drug distribution. Standard adult doses assume an average weight of around 70 kilograms, but actual patient weights vary widely. Obese patients store lipophilic drugs in adipose tissue, which can prolong drug action and delay elimination. Conversely, malnourished patients or those with severe muscle wasting may have altered plasma protein binding. Midwives must calculate weight-based dosages carefully—especially for neonates or when administering potent drugs where a small miscalculation leads to severe overdose.
Inherited genetic differences influence how rapidly patients metabolize drugs. Liver enzymes, particularly the cytochrome P450 system, show genetic variations across different human populations. Some individuals are extensive metabolizers, processing drugs normally, while others are poor metabolizers who break medications down so slowly that standard doses accumulate dangerously. Conversely, ultra-rapid metabolizers clear drugs before they can exert a therapeutic effect. While routine genetic testing is rare in many routine Nigerian primary health clinics, midwives should remain alert to unexpected drug responses or treatment failures.
Disease states alter pharmacokinetic pathways dramatically. Renal disease impairs the excretion of water-soluble drugs and metabolites, causing dangerous buildup if doses are not reduced. Similarly, hepatic conditions like viral hepatitis or cirrhosis compromise the liver's ability to synthesize plasma proteins and metabolize xenobiotics. Cardiovascular disorders reduce perfusion to vital organs, slowing both the absorption of intramuscular injections and the delivery of drugs to their target receptors. Midwives caring for women with pre-eclampsia or severe systemic infections must anticipate these altered clearance rates.
External factors outside the internal physiology also shape drug responses. Dietary components can interact directly with medications; for instance, traditional herbal preparations and local dietary items can inhibit or induce hepatic enzymes. Co-administration of multiple drugs leads to drug-drug interactions, where one medication alters the absorption, protein binding, or excretion of another. Midwives should routinely ask antenatal and postnatal clients about herbal remedies, dietary supplements, and over-the-counter medications to prevent unexpected adverse outcomes.